Clinical trial
The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in…
NCT00273000 · Glostrup University Hospital, Copenhagen, Other · Unknown status
Key facts
| NCT number | NCT00273000 |
|---|---|
| Title | The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans |
| Official title | The Importance of Glucagon-Like Peptide-2 (GLP-2)in Mesenteric Bloodflow in Humans |
| Lead sponsor | Glostrup University Hospital, Copenhagen, Other |
| Collaborators | Rigshospitalet, Denmark University of Copenhagen |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | GLP-2 |
| Enrollment | 10 |
| Start date | Jan 1, 2006 |
| First posted | Jan 9, 2006 |
| Last update posted | Sep 11, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: